Aokang Medical (688613.SH) released its performance for the first three quarters, with a net income of 4.8882 million yuan, a year-on-year decrease of 90.95%.

Zhitong Finance · Oct 28 23:28

Ouji Medical (688613.SH) disclosed its third quarter report for 2024, with the company achieving revenue in the first three quarters...

According to the Zhitong Financial APP, Ouji Medical (688613.SH) disclosed its third quarter report for 2024, with the company achieving revenue of 0.148 billion yuan, a decrease of 19.22% year-on-year. The net income attributable to shareholders of the listed company was 4.8882 million yuan, a decrease of 90.95% year-on-year. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 8.366 million yuan.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

奥精医疗(688613.SH)发布前三季度业绩 净利润488.82万元 同比下降90.95%

Aokang Medical (688613.SH) released its performance for the first three quarters, with a net income of 4.8882 million yuan, a year-on-year decrease of 90.95%.

Risk Disclaimer

Statement

奥精医疗(688613.SH)发布前三季度业绩净利润488.82万元同比下降90.95%